BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29787607)

  • 1. Differential sequences of exosomal NANOG DNA as a potential diagnostic cancer marker.
    Vaidya M; Bacchus M; Sugaya K
    PLoS One; 2018; 13(5):e0197782. PubMed ID: 29787607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sequences and single nucleotide polymorphism of exosomal SOX2 DNA in cancer.
    Vaidya M; Sugaya K
    PLoS One; 2020; 15(2):e0229309. PubMed ID: 32092088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of regulatory sequences in exosomal DNA of NANOGP8.
    Vaidya M; Smith J; Field M; Sugaya K
    PLoS One; 2023; 18(1):e0280959. PubMed ID: 36696426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for the Detection of Circulating Pseudogenes and Their Use as Cancer Biomarkers.
    Vaidya M; Sugaya K
    Methods Mol Biol; 2021; 2324():339-360. PubMed ID: 34165725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Restriction Endonuclease-Based Assay to Distinguish NANOGP8 Retrogene from Parental NANOG.
    Thakur H; Mattoo AR
    Methods Mol Biol; 2021; 2324():255-262. PubMed ID: 34165720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner.
    Kuciak M; Mas C; Borges I; Sánchez-Gómez P; Ruiz I Altaba A
    Sci Rep; 2019 Mar; 9(1):3891. PubMed ID: 30846719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NANOGP8: evolution of a human-specific retro-oncogene.
    Fairbanks DJ; Fairbanks AD; Ogden TH; Parker GJ; Maughan PJ
    G3 (Bethesda); 2012 Nov; 2(11):1447-57. PubMed ID: 23173096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of the NANOG pseudogene family in the human and chimpanzee genomes.
    Fairbanks DJ; Maughan PJ
    BMC Evol Biol; 2006 Feb; 6():12. PubMed ID: 16469101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small extracellular vesicles as tumor biomarkers for glioblastoma.
    Mahmoudi K; Ezrin A; Hadjipanayis C
    Mol Aspects Med; 2015 Nov; 45():97-102. PubMed ID: 26118341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longevity-Related Gene Transcriptomic Signature in Glioblastoma Multiforme.
    Fawzy MS; Badran DI; Al Ageeli E; Al-Qahtani SAM; Alghamdi SA; Helal GM; Toraih EA
    Oxid Med Cell Longev; 2018; 2018():8753063. PubMed ID: 29849920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal non-coding RNAs: a promising cancer biomarker.
    Yang H; Fu H; Xu W; Zhang X
    Clin Chem Lab Med; 2016 Dec; 54(12):1871-1879. PubMed ID: 27166723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells.
    Ambady S; Malcuit C; Kashpur O; Kole D; Holmes WF; Hedblom E; Page RL; Dominko T
    Int J Dev Biol; 2010; 54(11-12):1743-54. PubMed ID: 21136380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA Associated with Circulating Exosomes as a Biomarker for Glioma.
    Vaidya M; Sugaya K
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33137926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Cellular Transforming Activity of OCT4, NANOG, and SOX2 in Immortalized Astrocytes.
    Seo S; Jeon HY; Kim H
    DNA Cell Biol; 2017 Nov; 36(11):1000-1009. PubMed ID: 28933914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer.
    Donnarumma E; Fiore D; Nappa M; Roscigno G; Adamo A; Iaboni M; Russo V; Affinito A; Puoti I; Quintavalle C; Rienzo A; Piscuoglio S; Thomas R; Condorelli G
    Oncotarget; 2017 Mar; 8(12):19592-19608. PubMed ID: 28121625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprogramming activity of NANOGP8, a NANOG family member widely expressed in cancer.
    Palla AR; Piazzolla D; Abad M; Li H; Dominguez O; Schonthaler HB; Wagner EF; Serrano M
    Oncogene; 2014 May; 33(19):2513-9. PubMed ID: 23752184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome-packaged miR-1246 contributes to bystander DNA damage by targeting LIG4.
    Mo LJ; Song M; Huang QH; Guan H; Liu XD; Xie DF; Huang B; Huang RX; Zhou PK
    Br J Cancer; 2018 Aug; 119(4):492-502. PubMed ID: 30038324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NANOG overexpression and its correlation with stem cell and differentiation markers in meningiomas of different WHO grades.
    Freitag D; McLean AL; Simon M; Koch A; Grube S; Walter J; Kalff R; Ewald C
    Mol Carcinog; 2017 Aug; 56(8):1953-1964. PubMed ID: 28345785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.